FDA Approves Treosulfan with Fludarabine As a Preparative Regimen for alloHSCT in Adult and Paediatric Patients with AML or MDS By Ogkologos - March 13, 2025 619 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the MC-FludT.14/L Trial II Source RELATED ARTICLESMORE FROM AUTHOR Patient Guide in Testicular Cancer Now Available Also in Italian Adding 177Lu-PNT2002 to SBRT Significantly Improves PFS in Patients with Oligorecurrent Hormone-Sensitive Prostate Cancer A Short-Course Dose Escalation Strategy Could Improve Ability to Reach Target Dose of Adjuvant Abemaciclib in High-Risk Early-Stage HR-positive, HER2-negative Breast Cancer MOST POPULAR Take with Food: Study Tests Lowering Dose of Prostate Cancer Drug April 23, 2018 How I Learned to Advocate for Myself During Cancer: “Your Stories”... October 18, 2022 Newly Discovered ‘Don’t Eat Me’ Signal May be a Target for... August 20, 2019 Reunión anual de la American Society of Clinical Oncology de 2023:... June 5, 2023 Load more HOT NEWS Cooperativity of BRAF/MAPK Pathway Inhibition and Immune Checkpoint Blockade in Patients... Circulating T Cell Characteristics Associated with Immune Checkpoint Inhibitors-Induced irAEs FDA Approves Cabozantinib for Adults and Paediatric Patients 12 Years of... ΟΓΚΟΙ ΕΓΚΕΦΑΛΟΥ
